|
|
|
42
|
5521ZU
|
REMYCIN 100MG TAB (REM) DOXYCYCLINE
|
DOXYCYCLINE
|
REMYCIN
|
10X10
|
A
|
12.91
|
0.13
|
TAB
|
14
|
BLIS
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
081224
|
TETRACYCLINES
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
TETRACYCLINES
|
|
|
|
|
40
|
5522C
|
DOXYCYCLINE 100MG INJ (CIR/AHI)
|
DOXYCYCLINE
|
DOXYCYCLINE
|
100MG VIAL
|
B
|
35.23
|
35.23
|
INJECTION
|
0
|
VIAL
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081224
|
TETRACYCLINES
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
5522D
|
DOXYCYCLINE 100MG INJ (KWA/ATB)
|
DOXYCYCLINE
|
DOXYCYCLINE
|
100MG VIAL
|
B
|
29.14
|
29.14
|
INJECTION
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081224
|
TETRACYCLINES
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
5522D
|
DOXYCYCLINE 100MG INJ (KWA) (B)
|
DOXYCYCLINE
|
DOXYCYCLINE
|
100MG VIAL
|
B
|
26.34
|
26.3406
|
VIAL
|
28
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081224
|
TETRACYCLINES
|
2024-04-01
|
2026-03-31
|
|
IV
|
1
|
TETRACYCLINES
|
|
|
|
|
42
|
5522G
|
PLUGDOX 100MG INJ (SLS) DOXYCYCLINE
|
DOXYCYCLINE
|
PLUGDOX
|
100MG VIAL
|
BQ
|
25.01
|
25.01
|
VIAL
|
28
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081224
|
TETRACYCLINES
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
TETRACYCLINES
|
|
|
|
|
42
|
5522J
|
DOXYCYCLINE 100MG INJ (KWA)
|
DOXYCYCLINE
|
DOXYCYCLINE
|
100MG VIAL
|
BQ
|
38.22
|
38.22
|
VIAL
|
28
|
|
KWA
|
KWALITY PHARMACEUTICALS
|
STO
|
BRYDEN STOKES LTD
|
|
081224
|
TETRACYCLINES
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
TETRACYCLINES
|
2026-03-02
|
|
|
|
40
|
55311
|
EXFORGE 5MG | 80MG TAB (NVS/COL) AMLODIPINE | VAL
|
AMLODIPINE|VALSARTAN
|
EXFORGE
|
14'S
|
C
|
10.68
|
0.76
|
TABLET
|
0
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
240892
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
55311
|
EXFORGE 5MG|80MG TAB (NVS) AMLODIPINE|VA (C)
|
AMLODIPINE|VALSARTAN
|
EXFORGE
|
14'S
|
C
|
10.68
|
0.7631
|
TAB
|
60
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
240892
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
|
|
|
|
42
|
55311
|
EXFORGE 5MG|80MG TAB (NVS) AMLODIP (C)
|
AMLODIPINE|VALSARTAN
|
EXFORGE
|
14'S
|
C
|
9.65
|
0.69
|
TAB
|
60
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
B
|
240892
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
|
|
|
|
40
|
55314
|
TWYNSTA 5MG | 80MG TAB (BOE/STO) AMLODIPINE | TELMISARTAN
|
AMLODIPINE|TELMISARTAN
|
TWYNSTA
|
28'S
|
A
|
25.12
|
0.90
|
TABLET
|
30
|
TAB
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
B
|
240892
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
55314
|
TWYNSTA 5MG|80MG TAB (BOE) AMLODIPINE|TELMISARTAN
|
AMLODIPINE|TELMISARTAN
|
TWYNSTA
|
28'S
|
A
|
25.12
|
0.897
|
TAB
|
30
|
BOX
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
B
|
240892
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
|
|
|
|
42
|
55314
|
TWYNSTA 5MG|80MG TAB (BOE) AMLODIP (C)
|
AMLODIPINE|TELMISARTAN
|
TWYNSTA
|
28'S
|
A
|
25.12
|
0.90
|
TAB
|
30
|
BLIS
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
B
|
240892
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
|
|
|
|
42
|
55318
|
AMLOSHIP-VL 5MG|80MG TAB (FSB) AMLODIPINE|VALSARTAN
|
AMLODIPINE|VALSARTAN
|
AMLOSHIP-VL
|
10X10
|
A
|
8.92
|
0.09
|
TAB
|
60
|
|
FSB
|
FLAGSHIP BIOTECH
|
STO
|
BRYDEN STOKES LTD
|
B
|
240892
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2026-03-05
|
|
|
|
40
|
5531E
|
AMLOSHIP-VL 5MG | 80MG TAB (FSB/ATB) AMLODIPINE
|
AMLODIPINE|VALSARTAN
|
AMLOSHIP-VL
|
10X10
|
A
|
13.18
|
0.13
|
TABLET
|
30
|
TAB
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
240892
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
5531E
|
AMLOSHIP-VL 5MG|80MG TAB (FSB) AMLODIPIN (C)
|
AMLODIPINE|VALSARTAN
|
AMLOSHIP-VL
|
10X10
|
C
|
13.24
|
0.1324
|
TAB
|
60
|
BOX
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
240892
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
|
|
|
|
40
|
5531N
|
AMLODIPINE | VALSARTAN 5MG | 80MG TAB (MCP/AHI)
|
AMLODIPINE|VALSARTAN
|
AMLODIPINE|VALSARTAN
|
10X10
|
A
|
10.82
|
0.11
|
TABLET
|
30
|
TAB
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
240892
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
5531N
|
AMLODIPINE|VALSARTAN 5MG|80MG TAB (MCP)
|
AMLODIPINE|VALSARTAN
|
AMLODIPINE|VALSARTAN 5MG|80MG TAB
|
100'S
|
A
|
$8.66
|
0.0833
|
TABLET
|
30
|
TAB
|
MCP
|
MACLEODS PHARMACEUTICAL LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
240892
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2023-06-06
|
2024-03-31
|
A
|
ORAL
|
6
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2023-06-09
|
|
|
|
41
|
5531N
|
AMLODIPINE|VALSARTAN 5MG|80MG TAB (MCP)
|
AMLODIPINE|VALSARTAN
|
AMLODIPINE|VALSARTAN
|
10X10
|
A
|
9.27
|
0.0927
|
TAB
|
60
|
BOX
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
240892
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
|
|
|
|
40
|
55321
|
EXFORGE 5MG | 160MG TAB (NVS/COL) AMLODIPINE | VA
|
AMLODIPINE|VALSARTAN
|
EXFORGE
|
14'S
|
C
|
10.68
|
0.76
|
TABLET
|
0
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
240892
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
55321
|
EXFORGE 5MG|160MG TAB (NVS) AMLODIPINE|V (C)
|
AMLODIPINE|VALSARTAN
|
EXFORGE
|
14'S
|
C
|
10.68
|
0.7631
|
TAB
|
60
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
240892
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
|